T. Prodanov

发表

Response after surgical resection of metastatic pheochromocytoma and paraganglioma: can postoperative biochemical remission be predicted?

S. Steinberg, E. Kebebew, K. Pacak, 2013, Journal of the American College of Surgeons.

MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma

M. Urioste, P. Chanson, M. Blok, 2012, Clinical Cancer Research.

Clinical utility of chromogranin A in SDHx‐related paragangliomas

K. Pacak, G. Eisenhofer, R. Wesley, 2014, European journal of clinical investigation.

Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma.

F. Beuschlein, K. Pacak, H. Timmers, 2022, European journal of cancer.

Vascular Changes in the Retina and Choroid of Patients With EPAS1 Gain-of-Function Mutation Syndrome.

M. Gilbert, E. Chew, A. Pappo, 2019, JAMA ophthalmology.

New syndrome of paraganglioma and somatostatinoma associated with polycythemia.

A. Tischler, T. Fojo, M. Merino, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations.

T. Fojo, C. Stratakis, E. Kebebew, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Menstrual Cycle

L. Nelson, K. Calis, T. Prodanov, 2008, Annals of the New York Academy of Sciences.

CHARACTERISTICS AND OUTCOMES OF METASTATIC SDHB AND SPORADIC PHEOCHROMOCYTOMA/PARAGANGLIOMA: AN NATIONAL INSTITUTES OF HEALTH STUDY.

T. Fojo, J. Widimský, C. Stratakis, 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Clinical characteristics and outcomes of SDHB-related pheochromocytoma and paraganglioma in children and adolescents

C. Stratakis, K. Pacak, R. Wesley, 2020, Journal of Cancer Research and Clinical Oncology.

SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma

S. Steinberg, E. Kebebew, K. Pacak, 2017, Surgery.

Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra‐adrenal and metastatic tumors

E. Kebebew, K. Pacak, R. Aufforth, 2017, Surgery.

Genetic Screening for von Hippel-Lindau Gene Mutations in Non-syndromic Pheochromocytoma: Low Prevalence and False-positives or Misdiagnosis Indicate a Need for Caution

C. Vocke, A. Elkahloun, W. Linehan, 2012, Hormone and Metabolic Research.

Pheochromocytoma and paraganglioma syndromes: going on 2010

K. Pacak, G. Eisenhofer, V. Kantorovich, 2010 .

reviewPheochromocytoma and Paraganglioma syndromes : going on 2010

K. Pacak, G. Eisenhofer, V. Kantorovich, 2010 .

External Beam Radiation Therapy in Treatment of Malignant Pheochromocytoma and Paraganglioma

K. Camphausen, A. Fojo, B. Turkbey, 2014, Front. Oncol..

Immune signature of pheochromocytoma and paraganglioma in context of neuroendocrine neoplasms associated with prognosis

U. Shankavaram, M. Zeiger, Suman Ghosal, 2022, Endocrine.

A long noncoding RNA–microRNA expression signature predicts metastatic signature in pheochromocytomas and paragangliomas

U. Shankavaram, M. Zeiger, Suman Ghosal, 2021, Endocrine.

The Presence of SDHB Mutations Should Modify Surgical Indications for Carotid Body Paragangliomas

E. Kebebew, K. Pacak, N. Nilubol, 2014, Annals of surgery.

Malignant paraganglioma associated with succinate dehydrogenase subunit B in an 8-year-old child: the age of first screening?

K. Nathanson, K. Pacak, K. Adams, 2009, Pediatric Nephrology.

Preoperative genetic testing in pheochromocytomas and paragangliomas influences the surgical approach and the extent of adrenal surgery

E. Kebebew, K. Pacak, A. Gaitanidis, 2018, Surgery.

A. Fojo, K. Pacak, R. Wesley, 2017, Journal of Cancer Research and Clinical Oncology.

Succinate dehydrogenase gene mutations are strongly associated with paraganglioma of the organ of Zuckerkandl.

Kendall W. Cradic, M. Merino, C. Stratakis, 2010, Endocrine-related cancer.

Are patients with hormonally functional phaeochromocytoma and paraganglioma initially receiving a proper adrenoceptor blockade? A retrospective cohort study

T. Fojo, K. Pacak, R. Wesley, 2016, Clinical endocrinology.

Preoperative 18F-FDG PET/CT in Pheochromocytomas and Paragangliomas Allows for Precision Surgery

E. Kebebew, K. Pacak, A. Gaitanidis, 2019, Annals of surgery.

Human Cancer Biology MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma

M. Urioste, P. Chanson, M. Blok, 2012 .

Attention Deficit Hyperactivity Disorder in Pediatric Patients with Pheochromocytoma and Paraganglioma

C. Stratakis, M. Lodish, K. Pacak, 2016, Hormone and Metabolic Research.

Paediatric phaeochromocytoma and paraganglioma: A clinical update.

K. Pacak, T. Prodanov, A. Jha, 2023, Clinical endocrinology.

Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohort.

M. Fassnacht, K. Pacak, H. Timmers, 2023, The Lancet. Digital health.

Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma.

K. Pacak, H. Timmers, J. Lenders, 2022, Journal of Clinical Endocrinology and Metabolism.

The Presence of SDHB Mutations Should Modify Surgical Indications for Carotid Body Paragangliomas

E. Kebebew, K. Pacak, N. Nilubol, 2014, Annals of surgery.